MENINGITIS & ENCEPHALITIS - Ayushi.pptx pdf

302 views 36 slides Apr 02, 2024
Slide 1
Slide 1 of 36
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36

About This Presentation

Neurology


Slide Content

MENINGITIS BY – AYUSHI KOYANI (FY MPT) GUIDED BY – DR. VAISHALI SUTHAR MA’AM

CONTENTS Introduction Pathology Clinical features Investigations Complications Differential diagnosis Prognosis Treatment

INTRODUCTION

TYPES OF MENINGITIS

ACUTE BACTERIAL MENINGITIS Acute bacterial meningitis is an acute infection of the subarachnoid space and meninges characterizes by polymorphonuclear cells in the cerebrospinal fluid (CSF). Bacteria may invade the subarachnoid space directly by spread from contiguous structure, e.g. sinuses, or more commonly indirectly from the bloodstream.

Causative organisms In neonates – gram -ve bacilli, e.g. E. coli, Klebsiella. In children – Haemophiles influenzae. Pneumococcus, meningococcus In adults – Pneumococcus, Meningococcus Host factors – congenital or acquired immune deficiency, predispose to infection, overcrowding and poverty. May occur following head injury, mastoiditis or after lumbar puncture.

Nasopharyngeal colonisation Replication & growth Blood Subarachnoid Space invasion Replication of subarachnoid space Infection & inflammation of sub arachnoid space Pathology

Clinical features c/f are present on the basis of 3 main causes: Infection Increased ICP Meningeal inflammation & irritation Meningitis symptoms Severe frontal/occipital headache Stiff neck Fever, vomiting Photophobia

Meningitis sign : Neck stiffness Kernig's sign +ve Brudzinski's sign +ve

C/F ACCORDING TO STAGE OF MENINGITIS : STAGE-1 STAGE OF INVASION: Sudden onset Severe head ache Vomiting Fever Neck and back pain Convulsion Insomnia Severe confusion

STAGE-2 MENINGEAL STAGE : More severe head ache Lumbar pain Muscular stiffness & neck stiffness Kernig's & Brudzinski's signs +ve Muscular twitching & tenderness Temperature variable Exaggerated DTR Sensory loss Sensory neural deafness Pulse : slow & irregular

Continue… Pupils Unequal & sluggish reaction Dilated & fixed Ptosis Diplopia- double vision Seizures Other features Facial paralysis Dysphagia Incoordination Urine retention constipation

INVESTIGATION 1) CT SCAN : Excludes focal neurological deficit, increased ICP or other complications

2) CSF EXAMINATION : Increased pressure (>300 mm of H20) Purulent appearance Thick & greenish- pneumococcal Thin & yellow- strepto/ staphylococcal Increased total cell count >1000/ml Increased protein 1.0-5.0gm/lit Sugar decreased or absent Chloride & lactate decreased

3) Blood : Increased total blood count Increased ESR Culture isolate organism 4) Serum electrolytes : Increased frequency 5) X-ray : chest- pneumonia Skull- #

COMPLICATIONS 1) Septicaemia 2) Arthritis 3) neurological complications Cerebral oedema Focal neurological damage Psychiatric problems Hydrocephalus Cranial nerve palsies

4) Cardio-vascular complications Myocarditis Bacterial endocarditis 5) Electrolyte imbalance 6) Shock

DIFFERENTIAL DIAGNOSIS Poliomyelitis Acute disseminated encephalomyelitis Acute encephalitis Cerebral abscess Sub arachnoid haemorrhage

PROGNOSIS Over all prognosis- good Depends upon different factors E.g. Infective organism Response to antibiotics Stages of illness when pt comes Presence of complications Over all mortality- 15-25%

TREATMENT

PT EVALUATION OF THE PATIENT WITH MENINGITIS Observation of current functional status of the patient Assessment of standard vital signs Assessment of cognitive status Assessment of sensory integrity Assessment of movement abilities Assessment of functional abilities

AIMS OF THE PT INTERVENTIONS Optimization of postural control Optimization of functional activities with selective voluntary movement pattern control Improvement of performance of functional activities Enhancement of integration of sensory information Optimization of cognitive status and psychosocial responses

ENCEPHALITIS

INTRODUCTION Encephalitis is a non-suppurative inflammation of the parenchyma of the brain which contain neuronal and glial cell damage with associated inflammation and oedema. The inflammatory process can also involve the spinal cord i.e. encephalomyelitis. Viral encephalitis is a worldwide disorder with the highest incidence.

Virus causing encephalitis : Enterovirus Herpes simplex (usually type 1) Mumps virus Influenza virus Varicella zoster Japanese encephalitis virus

The most common virus responsible for large-scale epidemic in India is Japanese B encephalitis virus. It is spread by mosquito that extensively in rice ecosystem. In adults, >90% of cases of herpes simplex encephalitis result from infection with HSV-1. In children, influenza virus is an important cause of encephalitis.

CLINICAL FEATURES GENERAL : pyrexia, myalgia Specific to causative virus, Meningeal involvement (slight) – neck stiffness, cellular response in CSF. Sign and symptoms of parenchymal involvement – focal / diffuse.

INVESTIGATION CT SCAN : In temporal lobes with surrounding oedema. CSF : Increased pressure Protein levels are mildly elevated Cell count is increased EEG : periodic high voltage slow wave complexes over the involved temporal lobe.

DIFFERNTIAL DIAGNOSIS Post infectious encephalomyelitis Bacterial or tubercular infections of the brain

PROGNOSIS It is highly variable, in chronic cases high mortality is seen. Many may be left with residual deficit like dementia, focal deficits and epilepsy. Complications remain such as flexion deformities of arms, hyperextension of the legs, language impairment, learning difficulties and behavioral problems. Many recover completely if the illness is mild.

TREATMENT General measures to care for the unconscious patient should be started. Anticonvulsants are often necessary. Dexamethasone 4 mg 6 hourly for brain oedema. HSE responds well to acyclovir (10 mg/kg IV 8 hourly for 14-21 days)

The goals of therapeutic intervention program for patients with inflammatory CNS disorders :

REFERENCE Lindsay – Neurology & Neurosurgery Illustrated, 4 th edition Mathew – Medicine, 5 th edition Darcy – Umphred’s neurological rehabilitation, 6 th edition
Tags